Immunoblot analysis showed that both BCC- and CSC-derived EV preparations were enriched in the known EV markers, ALIX, CD9, and CD81 when compared with parental whole-cell lysates (Fig. 4B). The gene discussed is CD9; the disease is skin basal cell carcinoma.